{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:05:31Z","timestamp":1789754731416,"version":"4.0.1"},"reference-count":116,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,6,16]]},"abstract":"<jats:p>Eosinophilic gastritis (EoG) is a rare, chronic disease characterised by pathological eosinophilia of the stomach and gastrointestinal symptoms. Evidence suggests that pathophysiology is triggered by food antigens and driven by type 2 immune dysregulation, with upregulation of interleukins 4 and 13. Diagnosis is based on symptoms, endoscopic evaluation and abnormal gastric biopsies demonstrating dense eosinophilic infiltration, after exclusion of other potential causes of eosinophilia. There are currently no approved treatments for EoG, and existing therapeutic options\u2014including dietary elimination and off-label systemic or topical corticosteroids\u2014have suboptimal outcomes or are not appropriate for long-term use. Ongoing clinical studies of biologics in the field have the potential to impact clinical care.<\/jats:p>","DOI":"10.1136\/gutjnl-2025-337900","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:20:45Z","timestamp":1789752045000},"page":"gutjnl-2025-337900","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct03473977","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05251909","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03496571","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04322604","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04620811","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03678545","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05831176","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04322604","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04620811","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05251909","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05214768","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03678545","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05831176","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00084097","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04620811","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05251909","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05214768","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03678545","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05831176","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9790-6332","authenticated-orcid":false,"given":"Marc E","family":"Rothenberg","sequence":"first","affiliation":[{"name":"Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"Chehade","sequence":"additional","affiliation":[{"name":"Eosinophilic Gastrointestinal Disorders Program, Divisions of Pediatric and Adult Gastroenterology, NYU Grossman School of Medicine, New York City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1167-1101","authenticated-orcid":false,"given":"Evan S","family":"Dellon","sequence":"additional","affiliation":[{"name":"Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Collins","sequence":"additional","affiliation":[{"name":"Division of Pathology and Laboratory Medicine, Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center and Department of Pathology & Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2537-3092","authenticated-orcid":false,"given":"Nicholas J","family":"Talley","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health and Hunter Medical Research Institute, University of Newcastle, Callaghan, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margee","family":"Louisias","sequence":"additional","affiliation":[{"name":"Sanofi, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Bansal","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026091810202439000_gutjnl-2025-337900v1.1","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.cgh.2022.02.017","article-title":"International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.2","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jaci.2024.03.013","article-title":"Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases","volume":"153","author":"Shoda","year":"2024","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"2026091810202439000_gutjnl-2025-337900v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.047"},{"key":"2026091810202439000_gutjnl-2025-337900v1.4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MPG.0000000000000865","article-title":"Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database","volume":"62","author":"Jensen","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026091810202439000_gutjnl-2025-337900v1.5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.14309\/ajg.0000000000000228","article-title":"Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium","volume":"114","author":"Pesek","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.6","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jaip.2020.01.060","article-title":"Epidemiology of Nonesophageal Eosinophilic Gastrointestinal Diseases in Symptomatic Patients: A Systematic Review and Meta-Analysis","volume":"8","author":"Licari","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026091810202439000_gutjnl-2025-337900v1.7","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1007\/s10620-026-09835-4","article-title":"Prevalence and Costs of Non-esophageal Eosinophilic Gastrointestinal Diseases in the United States","volume":"71","author":"Aleman","year":"2026","journal-title":"Dig Dis Sci"},{"key":"2026091810202439000_gutjnl-2025-337900v1.8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10620-019-05617-3","article-title":"Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab","volume":"64","author":"Grandinetti","year":"2019","journal-title":"Dig Dis Sci"},{"key":"2026091810202439000_gutjnl-2025-337900v1.9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cgh.2011.07.017","article-title":"Natural history of eosinophilic gastroenteritis","volume":"9","author":"Pineton de Chambrun","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.14309\/ajg.0000000000001658","article-title":"Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis","volume":"117","author":"Dellon","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s10620-018-4978-7","article-title":"Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment","volume":"63","author":"Bedell","year":"2018","journal-title":"Dig Dis Sci"},{"key":"2026091810202439000_gutjnl-2025-337900v1.12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MPG.0000000000003877","article-title":"Joint ESPGHAN\/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis","volume":"78","author":"Papadopoulou","year":"2024","journal-title":"J pediatr gastroenterol nutr"},{"key":"2026091810202439000_gutjnl-2025-337900v1.13","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/apt.16396","article-title":"Letter: budesonide for functional dyspepsia with duodenal eosinophilia\u2014randomised, double\u2010blind, placebo\u2010controlled parallel\u2010group trial","volume":"53","author":"Talley","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2026091810202439000_gutjnl-2025-337900v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.05.050"},{"key":"2026091810202439000_gutjnl-2025-337900v1.15","first-page":"2434","article-title":"Overestimation of the diagnosis of eosinophilic colitis with reliance on billing codes","volume":"7","author":"Muir","year":"2019","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"key":"2026091810202439000_gutjnl-2025-337900v1.16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.12.015"},{"key":"2026091810202439000_gutjnl-2025-337900v1.17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.alit.2024.10.007","article-title":"Epidemiology and risk factors of non-esophageal eosinophilic gastrointestinal diseases in Japan: A population-based study","volume":"74","author":"Sawada","year":"2025","journal-title":"Allergol Int"},{"key":"2026091810202439000_gutjnl-2025-337900v1.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacig.2024.100260","article-title":"Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: A systematic review","volume":"3","author":"Chehade","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"key":"2026091810202439000_gutjnl-2025-337900v1.19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000511588","article-title":"Clinical Characteristics and Treatment Outcomes of Patients with Eosinophilic Esophagitis and Eosinophilic Gastroenteritis","volume":"102","author":"Okimoto","year":"2021","journal-title":"Digestion"},{"key":"2026091810202439000_gutjnl-2025-337900v1.20","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jaip.2020.12.054","article-title":"Diagnostic Delay in Patients with Eosinophilic Gastritis and\/or Duodenitis: A Population-Based Study","volume":"9","author":"Chehade","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026091810202439000_gutjnl-2025-337900v1.21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.gastha.2022.11.010","article-title":"Gastroenterology Practice Patterns Contribute to Missed Diagnoses of Eosinophilic Gastritis and Duodenitis","volume":"2","author":"Chehade","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"2026091810202439000_gutjnl-2025-337900v1.22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2025.09.030","article-title":"Epidemiology, Natural History, and Treatment of Eosinophilic Gastrointestinal Diseases","volume":"170","author":"Visaggi","year":"2026","journal-title":"Gastroenterology"},{"key":"2026091810202439000_gutjnl-2025-337900v1.23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/CEG.S173130","article-title":"Eosinophilic gastroenteritis: diagnosis and clinical perspectives","volume":"12","author":"Sunkara","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.11.013"},{"key":"2026091810202439000_gutjnl-2025-337900v1.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0429-z"},{"key":"2026091810202439000_gutjnl-2025-337900v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/86365"},{"key":"2026091810202439000_gutjnl-2025-337900v1.27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2023.05.024","article-title":"Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial","volume":"152","author":"Gonsalves","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/all.70183","article-title":"A Systematic Review and Meta-Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report","volume":"81","author":"Rossi","year":"2026","journal-title":"Allergy"},{"key":"2026091810202439000_gutjnl-2025-337900v1.29","first-page":"123","article-title":"A CASE OF EOSINOPHILIC GASTROENTERITIS FOUND BY PICA DURING ORAL IMMUNOTHERAPY","volume":"69","author":"Nishimura","year":"2020","journal-title":"Arerugi"},{"key":"2026091810202439000_gutjnl-2025-337900v1.30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/ped.14078","article-title":"Eosinophilic gastroenteritis developed after remission of cow\u2019s milk allergy","volume":"62","author":"Itoh","year":"2020","journal-title":"Pediatr Int"},{"key":"2026091810202439000_gutjnl-2025-337900v1.31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.aller.2016.05.002","article-title":"Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy","volume":"44","author":"Echeverr\u00eda-Zudaire","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2026091810202439000_gutjnl-2025-337900v1.32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.33","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaip.2017.03.030","article-title":"Gene Expression Patterns in Distinct Endoscopic Findings for Eosinophilic Gastritis in Children","volume":"5","author":"Sato","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026091810202439000_gutjnl-2025-337900v1.34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","article-title":"Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study","volume":"145","author":"Shoda","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"2026091810202439000_gutjnl-2025-337900v1.35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaci.2023.01.021","article-title":"Local type 2 immunity in eosinophilic gastritis","volume":"152","author":"Ben-Baruch Morgenstern","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.36","doi-asserted-by":"crossref","first-page":"101746","DOI":"10.1016\/j.clinre.2021.101746","article-title":"Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis","volume":"45","author":"Brenner","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.37","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.cgh.2020.08.013","article-title":"Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis","volume":"19","author":"Reed","year":"2021","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2026091810202439000_gutjnl-2025-337900v1.38","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197007000-00003"},{"key":"2026091810202439000_gutjnl-2025-337900v1.39","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.1.54"},{"key":"2026091810202439000_gutjnl-2025-337900v1.40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2024.01.009","article-title":"Dietary Management of Non-EoE Eosinophilic Gastrointestinal Diseases","volume":"44","author":"Chehade","year":"2024","journal-title":"Immunol Allergy Clin North Am"},{"key":"2026091810202439000_gutjnl-2025-337900v1.41","first-page":"5","article-title":"Clinical features and treatment outcomes of eosinophilic gastroenteritis: an analysis of 28 cases","volume":"82","author":"Yang","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"key":"2026091810202439000_gutjnl-2025-337900v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.04.022"},{"key":"2026091810202439000_gutjnl-2025-337900v1.43","first-page":"232","article-title":"Eosinophilic gastroenteritis: Clinical profiles and treatment outcomes, a retrospective study of 18 adult patients in a Singapore Tertiary Hospital","volume":"70","author":"Wong","year":"2015","journal-title":"Med J Malaysia"},{"key":"2026091810202439000_gutjnl-2025-337900v1.44","first-page":"522","article-title":"Eosinophilic Gastrointestinal Diseases Beyond the Esophagus: An Evolving Field and Nomenclature","volume":"18","author":"Redd","year":"2022","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2026091810202439000_gutjnl-2025-337900v1.45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.51821\/86.3.11869","article-title":"Non-esophageal eosinophilic gastrointestinal diseases: a narrative review","volume":"86","author":"Janssens","year":"2023","journal-title":"Acta Gastroenterol Belg"},{"key":"2026091810202439000_gutjnl-2025-337900v1.46","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000221903.61157.4e"},{"key":"2026091810202439000_gutjnl-2025-337900v1.47","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1308\/147870810X12659688851915","article-title":"Transmural eosinophilic gastritis with gastric outlet obstruction: case report and review of the literature","volume":"92","author":"Holroyd","year":"2010","journal-title":"annals"},{"key":"2026091810202439000_gutjnl-2025-337900v1.48","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3748\/wjg.v9.i12.2813","article-title":"Eosinophilic gastroenteritis: Clinical experience with 15 patients","volume":"9","author":"Chen","year":"2003","journal-title":"WJG"},{"key":"2026091810202439000_gutjnl-2025-337900v1.49","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000656","article-title":"Determination of Optimal Eosinophil Thresholds for Diagnosis of Eosinophilic Gastritis and Duodenitis: A Pooled Analysis of 4 Prospective Studies","volume":"15","author":"Dellon","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.50","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1007\/s10620-019-05961-4","article-title":"Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders","volume":"65","author":"Pesek","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2026091810202439000_gutjnl-2025-337900v1.51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.14309\/ajg.0000000000001625","article-title":"Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort","volume":"117","author":"Hirano","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cgh.2021.05.053","article-title":"Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and\/or Duodenitis in a Randomized Trial of Lirentelimab","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.53","doi-asserted-by":"crossref","DOI":"10.1007\/s11894-021-00809-2","article-title":"Eosinophilic Gastritis\/Gastroenteritis","volume":"23","author":"Chen","year":"2021","journal-title":"Curr Gastroenterol Rep"},{"key":"2026091810202439000_gutjnl-2025-337900v1.54","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cgh.2016.04.025","article-title":"Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders","volume":"14","author":"Dellon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.55","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000527","article-title":"Collagenous Gastritis Masquerading as Eosinophilic Gastritis","volume":"8","author":"Klein","year":"2021","journal-title":"ACG Case Rep J"},{"key":"2026091810202439000_gutjnl-2025-337900v1.56","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000481"},{"key":"2026091810202439000_gutjnl-2025-337900v1.57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.16971","article-title":"Non-oesophageal eosinophilic gastrointestinal diseases are undersuspected clinically and underdiagnosed pathologically","volume":"56","author":"Genta","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026091810202439000_gutjnl-2025-337900v1.58","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.5858\/arpa.2022-0204-OA","article-title":"Do General Pathologists Assess Gastric and Duodenal Eosinophilia?","volume":"147","author":"Saad","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"2026091810202439000_gutjnl-2025-337900v1.59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.dld.2014.11.009","article-title":"Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis","volume":"47","author":"Reed","year":"2015","journal-title":"Dig Liver Dis"},{"key":"2026091810202439000_gutjnl-2025-337900v1.60","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastha.2025.100627","article-title":"Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale","volume":"4","author":"Taft","year":"2025","journal-title":"Gastro Hep Adv"},{"key":"2026091810202439000_gutjnl-2025-337900v1.61","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.clinre.2018.03.003","article-title":"Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care","volume":"42","author":"Hiremath","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.62","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPG.0000000000002817","article-title":"High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases","volume":"71","author":"Jensen","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026091810202439000_gutjnl-2025-337900v1.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.11.008"},{"key":"2026091810202439000_gutjnl-2025-337900v1.64","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.cgh.2021.05.044","article-title":"Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases","volume":"20","author":"Reed","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.65","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13025","article-title":"Correlation between anxiety and decreased quality of life in patients with non-esophageal eosinophilic gastrointestinal diseases","volume":"8","author":"Tanaka","year":"2024","journal-title":"JGH Open"},{"key":"2026091810202439000_gutjnl-2025-337900v1.66","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1007\/s12325-022-02202-5","article-title":"The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States","volume":"39","author":"Woolley","year":"2022","journal-title":"Adv Ther"},{"key":"2026091810202439000_gutjnl-2025-337900v1.67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anai.2022.06.015","article-title":"Biologics in eosinophilic gastrointestinal diseases","volume":"130","author":"Dellon","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41390-019-0444-2","article-title":"Retrospective study of budesonide in children with eosinophilic gastroenteritis","volume":"86","author":"Fang","year":"2019","journal-title":"Pediatr Res"},{"key":"2026091810202439000_gutjnl-2025-337900v1.69","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jaip.2019.01.053","article-title":"Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience","volume":"7","author":"Kennedy","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026091810202439000_gutjnl-2025-337900v1.70","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.166"},{"key":"2026091810202439000_gutjnl-2025-337900v1.71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MPG.0000000000000766","article-title":"Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis","volume":"61","author":"Lucendo","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026091810202439000_gutjnl-2025-337900v1.72","doi-asserted-by":"crossref","DOI":"10.1111\/ped.14894","article-title":"Elemental diet therapy for eosinophilic gastroenteritis and dietary habits","volume":"64","author":"Higuchi","year":"2022","journal-title":"Pediatr Int"},{"key":"2026091810202439000_gutjnl-2025-337900v1.73","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jpc.15969","article-title":"Clinical, histopathological features and efficacy of elimination diet and proton-pump inhibitor therapy in achieving histological remission in Asian children with eosinophilic gastritis","volume":"58","author":"Ng","year":"2022","journal-title":"J Paediatr Child Health"},{"key":"2026091810202439000_gutjnl-2025-337900v1.74","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.alit.2022.11.001","article-title":"Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis","volume":"72","author":"Nagashima","year":"2023","journal-title":"Allergol Int"},{"key":"2026091810202439000_gutjnl-2025-337900v1.75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012047"},{"key":"2026091810202439000_gutjnl-2025-337900v1.76","unstructured":"EOS Network press release . Lirentelimab met histologic co-primary endpoints but missed symptomatic co-primary endpoints in both ENIGMA and KRYPTOS studies, 2021. Available: https:\/\/www.eosnetwork.org\/news\/lirentelimab-studies-meet-histologic-endpoints-but-miss-symptomatic-endpoints [Accessed 16 Mar 2026]."},{"key":"2026091810202439000_gutjnl-2025-337900v1.77","unstructured":"ClinicalTrials.gov . An extension study of lirentelimab in eosinophilic gastritis and\/or eosinophilic duodenitis (formerly referred to as eosinophilic gastroenteritis). 2024. Available: https:\/\/clinicaltrials.gov\/study\/NCT04620811 [Accessed 16 Mar 2026]."},{"key":"2026091810202439000_gutjnl-2025-337900v1.78","unstructured":"Allakos press release . Allakos announces topline phase 3 data from the EoDyssey study in patients with eosinophilic duodenitis, 2022. Available: https:\/\/investor.allakos.com\/news-releases\/news-release-details\/allakos-announces-topline-phase-3-data-eodyssey-study-patients [Accessed 16 Mar 2026]."},{"key":"2026091810202439000_gutjnl-2025-337900v1.79","unstructured":"US Food and Drug Administration . FASENRA\u00ae (benralizumab). Highlights of prescribing information. 2024."},{"key":"2026091810202439000_gutjnl-2025-337900v1.80","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa1812185","article-title":"Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome","volume":"380","author":"Kuang","year":"2019","journal-title":"N Engl J Med"},{"key":"2026091810202439000_gutjnl-2025-337900v1.81","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2468-1253(23)00145-0","article-title":"Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.82","unstructured":"ClinicalTrials.gov . Efficacy and safety of benralizumab in patients with eosinophilic gastritis and\/or gastroenteritis (the HUDSON GI study), Available: https:\/\/clinicaltrials.gov\/study\/NCT05251909 [Accessed 16 Mar 2026]."},{"key":"2026091810202439000_gutjnl-2025-337900v1.83","unstructured":"US Food and Drug Administration . NUCALA\u00ae (mepolizuma). Highlights of prescribing information. 2017."},{"key":"2026091810202439000_gutjnl-2025-337900v1.84","unstructured":"US Food and Drug Administration . CINQUAIR\u00ae (reslizumab). Highlights of prescribing information. 2016."},{"key":"2026091810202439000_gutjnl-2025-337900v1.85","doi-asserted-by":"crossref","DOI":"10.1016\/S0091-6749(03)80986-7","article-title":"Pilot study of anti-IL-5 in eosinophilic gastroenteritis","volume":"111","author":"Prussin","year":"2003","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"2026091810202439000_gutjnl-2025-337900v1.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.08.027"},{"key":"2026091810202439000_gutjnl-2025-337900v1.87","doi-asserted-by":"crossref","DOI":"10.1186\/s13223-020-00423-3","article-title":"Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report","volume":"16","author":"Caruso","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.88","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.anai.2018.07.030","article-title":"Severe asthma with eosinophilic gastroenteritis effectively managed by mepolizumab and omalizumab","volume":"121","author":"Han","year":"2018","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"2026091810202439000_gutjnl-2025-337900v1.89","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.2169\/internalmedicine.0801-22","article-title":"Successful Treatment of Steroid-resistant Eosinophilic Gastrointestinal Disease with Mepolizumab","volume":"62","author":"Ito","year":"2023","journal-title":"Intern Med"},{"key":"2026091810202439000_gutjnl-2025-337900v1.90","article-title":"The Unusual Clinical Presentation of Eosinophilic Gastroenteritis and Its Response to Mepolizumab: Two Case Reports","volume":"16","author":"Kiblawi","year":"2024","journal-title":"Cureus"},{"key":"2026091810202439000_gutjnl-2025-337900v1.91","unstructured":"US Food and Drug Administration . ENTYVIO\u00ae (vedolizumab). Highlights of prescribing information. 2022."},{"key":"2026091810202439000_gutjnl-2025-337900v1.92","doi-asserted-by":"crossref","unstructured":"Galindo Garc\u00eda C , Moreno Pimentel C , Serrano Gim\u00e9nez R , et al . EOSINOPHILIC COLITIS WITH FAVORABLE RESPONSE TO VEDOLIZUMAB. Rev Esp Enferm Dig 2024. doi:10.17235\/reed.2024.10660\/2024","DOI":"10.17235\/reed.2024.10660\/2024"},{"key":"2026091810202439000_gutjnl-2025-337900v1.93","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.cgh.2018.03.024","article-title":"Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis","volume":"16","author":"Kim","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.94","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5217\/ir.2024.00013","article-title":"Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report","volume":"23","author":"Takedomi","year":"2025","journal-title":"Intest Res"},{"key":"2026091810202439000_gutjnl-2025-337900v1.95","unstructured":"Dellon ES , Charriez CM , Zhang S , et al . 43 - cendakimab efficacy and safety in adult and adolescent patients with eosinophilic esophagitis 48-week results from the randomized, placebo-controlled, phase 3 study (late-breaking abstract). ACG 2024 Annual Scientific Meeting; Philadelphia, PA, USA, October 25\u201330; 2024"},{"key":"2026091810202439000_gutjnl-2025-337900v1.96","unstructured":"ClinicalTrials.gov . A study to evaluate the efficacy and safety of cc-93538 in adult and adolescent japanese participants with eosinophilic gastroenteritis. 2025. Available: https:\/\/clinicaltrials.gov\/study\/NCT05214768 [accessed 16 Mar 2026]"},{"key":"2026091810202439000_gutjnl-2025-337900v1.97","unstructured":"US Food and Drug Administration . DUPIXENT\u00ae (dupilumab). Highlights of prescribing information. 2024."},{"key":"2026091810202439000_gutjnl-2025-337900v1.98","unstructured":"European Medicines Agency . DUPIXENT\u00ae (dupilumab). Summary of product characteristics. 2024."},{"key":"2026091810202439000_gutjnl-2025-337900v1.99","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000646","article-title":"Dupilumab Can Induce Remission of Eosinophilic Gastritis and Duodenitis: A Retrospective Case Series","volume":"15","author":"Sia","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/MPG.0000000000003512","article-title":"A Case Series on the Use of Dupilumab for Treatment of Refractory Eosinophilic Gastrointestinal Disorders","volume":"75","author":"Patel","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026091810202439000_gutjnl-2025-337900v1.101","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010112","article-title":"Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders","volume":"13","author":"Arakawa","year":"2023","journal-title":"Biomolecules"},{"key":"2026091810202439000_gutjnl-2025-337900v1.102","unstructured":"ClinicalTrials.gov . Dupilumab in eosinophilic gastritis, 2025. Available: https:\/\/clinicaltrials.gov\/study\/NCT03678545 [Accessed 16 Mar 2026]."},{"key":"2026091810202439000_gutjnl-2025-337900v1.103","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2468-1253(26)00116-0","article-title":"Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial","volume":"11","author":"Gonsalves","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.104","unstructured":"ClinicalTrials.gov . A trial to learn if dupilumab is safe for and helps adult and adolescent participants with eosinophilic gastritis with or without eosinophilic duodenitis and the side effects it may have (engage). 2025. Available: https:\/\/clinicaltrials.gov\/study\/NCT05831176 [Accessed 16 Mar 2026]."},{"key":"2026091810202439000_gutjnl-2025-337900v1.105","unstructured":"US Food and Drug Administration . XOLAIR\u00ae (omalizumab). Highlights of prescribing information. 2024."},{"key":"2026091810202439000_gutjnl-2025-337900v1.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.06.015"},{"key":"2026091810202439000_gutjnl-2025-337900v1.107","doi-asserted-by":"publisher","DOI":"10.1186\/1476-7961-9-7"},{"key":"2026091810202439000_gutjnl-2025-337900v1.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.09.039"},{"key":"2026091810202439000_gutjnl-2025-337900v1.109","doi-asserted-by":"crossref","first-page":"299","DOI":"10.14744\/TurkPediatriArs.2018.48376","article-title":"Eosinophilic gastroenteritis as a cause of gastrointestinal tract bleeding and protein-losing enteropathy","volume":"55","author":"Eren","year":"2020","journal-title":"Turk Pediatri Ars"},{"key":"2026091810202439000_gutjnl-2025-337900v1.110","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.53.2111"},{"key":"2026091810202439000_gutjnl-2025-337900v1.111","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.alit.2015.06.002","article-title":"Proton pump inhibitor treatment decreased duodenal and esophageal eosinophilia in a case of eosinophilic gastroenteritis","volume":"64","author":"Yamada","year":"2015","journal-title":"Allergology International"},{"key":"2026091810202439000_gutjnl-2025-337900v1.112","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12876-021-01854-x","article-title":"Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review","volume":"21","author":"El-Alali","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"2026091810202439000_gutjnl-2025-337900v1.113","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067554","article-title":"Neuropsychiatric reactions with the use of montelukast","volume":"376","author":"Ekhart","year":"2022","journal-title":"BMJ"},{"key":"2026091810202439000_gutjnl-2025-337900v1.114","doi-asserted-by":"crossref","DOI":"10.1126\/science.adp0246","article-title":"Intestinal mast cell-derived leukotrienes mediate the anaphylactic response to ingested antigens","volume":"389","author":"Bachtel","year":"2025","journal-title":"Science"},{"key":"2026091810202439000_gutjnl-2025-337900v1.115","doi-asserted-by":"crossref","DOI":"10.1126\/science.adp0240","article-title":"Cysteinyl leukotrienes stimulate gut absorption of food allergens to promote anaphylaxis in mice","volume":"389","author":"Hoyt","year":"2025","journal-title":"Science"},{"key":"2026091810202439000_gutjnl-2025-337900v1.116","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41575-025-01086-4","article-title":"The oesophagus as an immune organ","volume":"22","author":"Rochman","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-337900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:20:56Z","timestamp":1789752056000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-337900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":116,"alternative-id":["10.1136\/gutjnl-2025-337900"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-337900","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}